Covance Is Now Labcorp Drug Development

We are one global company innovating for millions – together, continuing to bring you more advanced medical breakthroughs.

Learn More

Info Sheets

A Patient-Centric Approach to Advance IPF Drug Development

Our patient-first point of view helps us shape successful idiopathic pulmonary fibrosis (IPF) studies. Learn how our experienced team strives to be more than a partner. Together, we can make your trial more attractive to potential participants and promote increased recruitment and retention rates in today's highly competitive respiratory studies. We're here to help your program succeed.

Filed In

Commercialization
Info Sheets
Patient Centricity
Pharma
Phase IIb
Pulmonary & Respiratory
Stage (Early, PhI-IIa)